竞争风险列线图预测胃癌D2术后初始局部区域复发
该回顾性研究纳入1105例I-III期胃癌D2根治术后患者,基于Fine和Grey竞争风险分析构建预测初始局部区域复发的列线图。多因素分析显示年龄、CEA、pT4、淋巴结转移和LVI为独立危险因素,列线图C-index为0.738。作者建议对高龄或pN+、pT4、LVI、CEA升高患者考虑辅助放疗,并将16a2和16b1腹主动脉旁淋巴结纳入CTV。
要点
- 年龄、CEA、pT4、淋巴结转移和LVI是胃癌D2术后局部区域复发的独立危险因素。
- 列线图预测初始局部区域复发的C-index为0.738,校准良好。
- 腹主动脉旁淋巴结是最常见复发部位,16a2和16b1占比最高。
核心结论
- 竞争风险列线图可作为胃癌D2术后局部区域复发的个体化预测工具。
- 对≥65岁或pN+、pT4、LVI、CEA升高的胃癌患者可考虑推荐辅助放疗。
- 建议临床靶区(CTV)包括腹主动脉旁16a2和16b1区域淋巴结。
研究设计与样本
- 回顾性分析1105例接受D2根治术的I-III期胃癌患者。
- 基于Fine和Grey竞争风险分析构建预测初始局部区域复发的列线图。
- 采用一致性指数(C-index)和校准曲线评估模型预测准确性和区分度,并进行决策树分析用于患者分组。
主要发现
- 中位随访28.4个月,274例患者发生373次首次复发事件(局部、区域和远处),中位无复发生存期(RFS)为16.7个月。
- 多因素竞争风险分析显示,年龄(SHR 1.72,95%CI 1.10-2.83,p=0.031)、CEA(SHR 1.94,95%CI 1.09-3.46,p=0.024)、pT4(SHR 2.77,95%CI 1.01-7.57,p=0.047)、淋巴结转移(SHR 1.92,95%CI 1.09-3.38,p=0.024)和LVI(SHR 1.84,95%CI 1.06-3.20,p=0.028)是局部区域复发的独立危险因素。
- 列线图预测与实际观察一致性良好,C-index为0.738(95%CI 0.767-0.709)。
- 淋巴结阳性亚组分析中,pN3b与腹膜和远处转移增加相关(p=0.048)。
- 腹主动脉旁淋巴结是最常见的局部区域复发部位(n=71),其中16a2和16b1淋巴结占比分别为90.1%和81.7%。
关键数值与推荐
- 年龄、CEA、pT4、淋巴结转移和LVI为局部区域复发的独立危险因素(均p<0.05)。
- 列线图C-index为0.738(95%CI 0.767-0.709)。
- pN3b与腹膜和远处转移增加相关(p=0.048)。
- 腹主动脉旁淋巴结复发中16a2和16b1分别占90.1%和81.7%。
临床怎么用
- 可依据年龄、CEA、pT4、淋巴结转移和LVI等因子评估胃癌D2术后局部区域复发风险。
- 对≥65岁或pN+、pT4、LVI、CEA升高的患者,可考虑推荐辅助放疗。
- 放疗临床靶区(CTV)建议包括腹主动脉旁16a2和16b1区域淋巴结。
局限性
- 回顾性研究设计。
- 未报告外部验证结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lacking quantitative evaluations of clinicopathological features and the risk factors for loco-regional recurrence (LRR) in gastric cancer after D2 gastrectomy, we aimed to develop a competing risk nomogram to identify the risk predictors for initial LRR. METHODS: We retrospectively analysed 1105 patients who underwent radical gastrectomy with D2 resection for stage I-III gastric cancer. A nomogram predicting initial LRR of gastric cancer was conducted based on Fine and Grey's competing risk analysis. The predictive accuracy and discriminative ability of the model were determined using the concordance index (C-index) and calibration curve. Decision tree analysis was performed for patient grouping. RESULTS: At a median follow-up of 28.4 months, 274 patients developed 373 first recurrence events (local, regional, and distant disease). The median recurrence-free survival (RFS) was 16.7 months. Multivariate competing risk analysis showed that age (SHR, 1.72; 95% CI, 1.10-2.83, p = 0.031), CEA (SHR, 1.94; 95% CI, 1.09-3.46, p = 0.024), pT4 (SHR, 2.77; 95% CI, 1.01-7.57, p = 0.047), lymph node metastasis (SHR 1.92, 95% CI: 1.09-3.38, p = 0.024) and LVI (SHR, 1.84; 95% CI, 1.06-3.20, p = 0.028) were independent risk factors for LRR (all p < 0.05). The nomogram incorporating these factors achieved good agreement between prediction and actual observation with a concordance index of 0.738 (95% CI, 0.767 to 0.709). In a subgroup analysis of node-positive patients, pN3b was associated with increased peritoneal and distant metastasis (p = 0.048). The para-aortic lymph nodes were the most frequent sites (n = 71) of LRR, and among them, the 16a2 and 16b1 nodes exhibited even more prevalence (90.1 and 81.7%). CONCLUSIONS: Adjuvant radiotherapy might be recommended in gastric cancer patients ≥65 years old or those with pN+, pT4, LVI, or increased CEA levels, particularly in high-risk or pN1-3a patients. The competing risk nomograms may be considered as convenient and individualized predictive tools for LRR in gastric cancer after D2 gastrectomy. It is also recommended that the clinical target volume (CTV) include 16a2 and 16b1 regions of para-aortic lymph nodes.
引用
- Wang SB, Qi WX, Chen JY, et al. Competing risk nomogram predicting initial loco-regional recurrence in gastric cancer patients after D2 gastrectomy. Radiat Oncol. 2019. PMID: 31315683. doi:10.1186/s13014-019-1332-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。